Publicaciones en colaboración con investigadores/as de Fundación Jiménez Díaz (17)

2017

  1. 2017 update on the relationship between diabetes and colorectal cancer: Epidemiology, potential molecular mechanisms and therapeutic implications

    Oncotarget, Vol. 8, Núm. 11, pp. 18456-18485

2015

  1. Biocompatibility reduces inflammation-induced apoptosis in mesothelial cells exposed to peritoneal dialysis Fluid

    Blood Purification, Vol. 39, Núm. 1-3, pp. 200-209

2014

  1. Endogenous NAMPT dampens chemokine expression and apoptotic responses in stressed tubular cells

    Biochimica et Biophysica Acta - Molecular Basis of Disease, Vol. 1842, Núm. 2, pp. 293-303

  2. Osteoprotegerin and kidney disease

    Journal of Nephrology, Vol. 27, Núm. 6, pp. 607-617

  3. TWEAK and the progression of renal disease: Clinical translation

    Nephrology Dialysis Transplantation, Vol. 29, Núm. SUPPL. 1

  4. Unilateral ureteral obstruction: Beyond obstruction

    International Urology and Nephrology, Vol. 46, Núm. 4, pp. 765-776

2013

  1. Laser therapy in metabolic syndrome-related kidney injury

    Photochemistry and Photobiology, Vol. 89, Núm. 4, pp. 953-960

  2. TNF-related weak inducer of apoptosis (TWEAK) promotes kidney fibrosis and Ras-dependent proliferation of cultured renal fibroblast

    Biochimica et Biophysica Acta - Molecular Basis of Disease, Vol. 1832, Núm. 10, pp. 1744-1755

2010

  1. TNF superfamily: A growing saga of kidney injury modulators

    Mediators of Inflammation, Vol. 2010

  2. Unravelling fibrosis: Two newcomers and an old foe

    Nephrology Dialysis Transplantation, Vol. 25, Núm. 11, pp. 3492-3495

2009

  1. A nanoconjugate Apaf-1 inhibitor protects mesothelial cells from cytokine-induced injury

    PLoS ONE, Vol. 4, Núm. 8

  2. La transcriptómica ilustra nuevas vías letales en la nefropatía diabética

    Nefrologia, Vol. 29, Núm. 1, pp. 13-19

  3. TRAIL and kidney disease

    Frontiers in Bioscience, Vol. 14, Núm. 10, pp. 3740-3749

2008

  1. 3,4-Dideoxyglucosone-3-ene as a mediator of peritoneal demesothelization

    Nephrology Dialysis Transplantation, Vol. 23, Núm. 10, pp. 3307-3315

  2. Apoptosis: From advances in PD to therapeutic targets in DM

    Nefrologia

  3. TWEAKing renal injury

    Frontiers in Bioscience, Vol. 13, Núm. 2, pp. 580-589

  4. The death ligand TRAIL in diabetic nephropathy

    Journal of the American Society of Nephrology, Vol. 19, Núm. 5, pp. 904-914